INNOCARE PHARMA LTD

Research INNOCARE PHARMA LTD (33C) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• Ticker33C
• ExchangeF
• CurrencyEUR
• Financial periodFY2024
• RevenueEUR 1.01B
• Revenue growth36.7%
• Net income-EUR 440.63M
• Free cash flow-EUR 443.78M
• Gross margin86.3%